Published in Cancer Weekly, September 25th, 2001
"To elucidate the tumor-suppressive function of [PTEN], we have been analyzing expression profiles of cancer cells after introduction of exogenous PTEN," reported M. Unoki and colleagues at the University of Tokyo.
Of 99 candidate genes that were transcriptionally transactivated, the researchers further analyzed of eight of them and found that expression of six - (PINK], EGR2, HCLS1, DUSP1, BPOZ, and NFIL3 - was decreased...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.